94-23036. Delegations of Authority and Organization; Counterfeit Drugs Enforcement Activities  

  • [Federal Register Volume 59, Number 180 (Monday, September 19, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-23036]
    
    
    [[Page Unknown]]
    
    [Federal Register: September 19, 1994]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 5
    
     
    
    Delegations of Authority and Organization; Counterfeit Drugs 
    Enforcement Activities
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the 
    regulations for delegations of authority relating to enforcement 
    activities. The amendment designates FDA officers or employees who have 
    been issued official credential FDA-200D to administer oaths and 
    affirmations for use in any prosecution or proceeding under or in the 
    enforcement of any law enforced by FDA.
    
    EFFECTIVE DATE: September 19, 1994.
    
    FOR FURTHER INFORMATION CONTACT: John L. Paolino, Jr., Office of 
    Criminal Investigations (HFC-300), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-294-4030, or Ellen Rawlings, 
    Division of Management Systems and Policy (HFA-340), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-4976.
    
    SUPPLEMENTARY INFORMATION: FDA is amending the regulations for 
    delegations of authority for Sec. 5.35 Enforcement activities (21 CFR 
    5.35) by designating FDA officers and employees who have been issued 
    official credential FDA-200D, Special Authority for Criminal 
    Investigators, the authority to administer oaths and affirmations for 
    use in any prosecution or proceeding under or in the enforcement of any 
    law enforced by FDA. This authority is the same as that delegated to 
    holders of FDA-200A and FDA-200B credentials. This authority may not be 
    redelegated.
    
     List of Subjects in 21 CFR Part 5
    
         Authority delegations (Government agencies), Imports, Organization 
    and functions (Government agencies).
    
         Therefore, under the Federal Food, Drug, and Cosmetic Act and 
    under authority delegated to the Commissioner of Food and Drugs, 21 CFR 
    part 5 is amended as follows:
    
     PART 5--DELEGATIONS OF AUTHORITY AND ORGANIZATION
    
         1. The authority citation for 21 CFR part 5 continues to read as 
    follows:
    
         Authority: 5 U.S.C. 504, 552, App. 2; 7 U.S.C. 138a, 2271; 15 
    U.S.C. 638, 1261-1282, 3701-3711a; secs. 2-12 of the Fair Packaging 
    and Labeling Act (15 U.S.C. 1451-1461); 21 U.S.C. 41-50, 61-63, 141-
    149, 467f, 679(b), 801-886, 1031-1309; secs. 201-903 of the Federal 
    Food, Drug, and Cosmetic Act (21 U.S.C. 321-394); 35 U.S.C. 156; 
    secs. 301, 302, 303, 307, 310, 311, 351, 352, 361, 362, 1701-1706, 
    2101, 2125, 2127, 2128 of the Public Health Service Act (42 U.S.C. 
    241, 242, 242a, 242l, 242n, 243, 262, 263, 264, 265, 300u-300u-5, 
    300aa-1, 300aa-25, 300aa-27, 300aa-28); 42 U.S.C. 1395y, 3246b, 
    4332, 4831(a), 10007-10008; E.O. 11490, 11921, and 12591; secs. 312, 
    313, 314 of the National Childhood Vaccine Injury Act of 1986, Pub. 
    L. 99-660 (42 U.S.C. 300aa-1 note).
    
         2. Section 5.35 is amended by adding new paragraph (b)(3) to read 
    as follows:
    
    
    Sec. 5.35  Enforcement activities.
    
     * * * * *
         (b)(3) To administer oaths and affirmations under section 1 of the 
    act of January 31, 1925 (Ch. 124, 43 Stat. 803); sections 12 to 15 of 
    Reorganization Plan No. IV, effective June 30, 1940; and Reorganization 
    Plan No. 1 of 1953, effective April 11, 1953.
     * * * * *
    
        Dated: September 9, 1994.
    Gary Dykstra,
    Acting Associate Commissioner for Regulatory Affairs.
    [FR Doc. 94-23036 Filed 9-16-94; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
09/19/1994
Department:
Food and Drug Administration
Entry Type:
Uncategorized Document
Action:
Final rule.
Document Number:
94-23036
Dates:
September 19, 1994.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: September 19, 1994
CFR: (1)
21 CFR 5.35